FDA Adverse Event
Injury
Summary report: N
ENDOTAK RELIANCE
MDR report key: 3213141
·
Received July 9, 2013
Report
- Report Number
- 2124215-2013-10454
- Event Type
- Injury
- Date Received
- July 9, 2013
- Date of Event
- May 30, 2013
- Report Date
- November 6, 2015
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVY
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CT
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING THE IMPLANT OF THIS RIGHT VENTRICULAR (RV) LEAD, THE PATIENT DEVELOPED PERICARDIAL EFFUSION THAT WAS DETECTED THROUGH AN ECHOCARDIOGRAM. THE LEAD WAS IMPLANTED AND NO ADDITONAL INTERVENTIONS WERE NEEDED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 312258 | ENDOTAK RELIANCE | NVY | CPI - DEL CARIBE | 0295 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 71 YR | Life Threatening | E142| 4136 |